qbryy7zm | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/qbryy7zm_hasAnnotation_C1827106>
?:creator	<https://research.tib.eu/covid-19/entity/Solerte%2C_Sebastiano_Bruno%3B_D%E2%80%99Addio%2C_Francesca%3B_Fiorina%2C_Paolo>
?:doi	<https://research.tib.eu/covid-19/entity/10.1007/s00592-020-01630-5>
?:doi	10.1007/s00592-020-01630-5
?:journal	Acta_Diabetol
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/23bfe42d082db896aa31576b8a51ef13fa0b2846.json
?:pmc_json_files	document_parses/pmc_json/PMC7669486.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7669486>
?:pmid	<https://research.tib.eu/covid-19/entity/33201344.0>
?:pmid	33201344.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/23bfe42d082db896aa31576b8a51ef13fa0b2846>
?:source	Medline; PMC
?:title	Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19”
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-17

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/qbryy7zm>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/qbryy7zm>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all